Almitas Capital LLC An2 Therapeutics, Inc. Transaction History
Almitas Capital LLC
- $177 Million
- Q1 2025
A detailed history of Almitas Capital LLC transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Almitas Capital LLC holds 1,313,111 shares of ANTX stock, worth $1.56 Million. This represents 1.01% of its overall portfolio holdings.
Number of Shares
1,313,111
Previous 1,313,111
-0.0%
Holding current value
$1.56 Million
Previous $1.79 Million
-0.0%
% of portfolio
1.01%
Previous 0.87%
Shares
1 transactions
Others Institutions Holding ANTX
# of Institutions
38Shares Held
13.7MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN5.75MShares$6.84 Million6.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.04MShares$1.23 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1MShares$1.19 Million0.0% of portfolio
-
Peapod Lane Capital LLC Bedford Hills, NY581KShares$691,2150.89% of portfolio
-
Bank Of Nova Scotia459KShares$546,4400.0% of portfolio
About AN2 Therapeutics, Inc.
- Ticker ANTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 19,402,700
- Market Cap $23.1M
- Description
- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...